Off-Trial Evaluation of the B cell-Targeting Treatment in the Refractory Cases of Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis: Long-Term Follow-Up from a Single Centre-Reference-Cited by-同舟云学术

Off-Trial Evaluation of the B cell-Targeting Treatment in the Refractory Cases of Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis: Long-Term Follow-Up from a Single Centre

Published:2012-09-12 Issue:4 Volume:76 Page:411-420
ISSN:0300-9475
Container-title:Scandinavian Journal of Immunology
language:en
Short-container-title:

Author:

Pullerits R.,Ljevak M.,Vikgren J.,Bokarewa M.

Publisher

Wiley

Subject

Immunology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-3083.2012.02747.x/fullpdf

Reference28 articles.

1. Anti-neutrophil cytoplasmic antibodies and disease activity during long-term follow-up of 70 patients with systemic vasculitis;Gaskin;Nephrol Dial Transplant,1991

2. Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice;Xiao;J Clin Invest,2002

3. Rituximab and Wegener’s granulomatosis: are B cells a target in vasculitis treatment?;Sneller;Arthritis Rheum,2005

4. Differential B- and T-cell activation in Wegener’s granulomatosis;Popa;J Allergy Clin Immunol,1999

5. Giant-cell granuloma of the respiratory tract (Wegener’s granulomatosis);Walton;Br Med J,1958

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Efficacy and Safety of Rituximab in ANCA-Associated Vasculitis: A Systematic Review;Biology;2022-12-06

2. Comparison of Two Rituximab Induction Regimens for Antineutrophil Cytoplasm Antibody–Associated Vasculitis: Systematic Review and Meta‐Analysis;ACR Open Rheumatology;2021-06-11

3. Severe infections in patients with ANCA-associated vasculitis treated with rituximab;Rheumatology;2021-03-23

4. Severe infections in patients with anti-neutrophil cytoplasmic antibody-associated vasculitides receiving rituximab: A meta-analysis;Autoimmunity Reviews;2020-05

5. Cancer risks along the disease trajectory in antineutrophil cytoplasmic antibody associated vasculitis;Clinical Rheumatology;2020-03-26